Commentary on “The clinical utility and outcomes of hemospray as primary versus salvage therapeutic modality for endoscopic hemostasis: A retrospective cohort study”

Sheldon S. Smith, Andrew T. Mertz, Jerome C. Edelson

Open source

DOI
10.1177/10815589261483672
Published
2026-08-27
Container
Journal of Investigative Medicine
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10815589261483672,
  title = {Commentary on “The clinical utility and outcomes of hemospray as primary versus salvage therapeutic modality for endoscopic hemostasis: A retrospective cohort study”},
  author = {Sheldon S. Smith and Andrew T. Mertz and Jerome C. Edelson},
  year = {2026},
  journal = {Journal of Investigative Medicine},
  doi = {10.1177/10815589261483672},
  url = {https://doi.org/10.1177/10815589261483672}
}

RIS

TY  - JOUR
TI  - Commentary on “The clinical utility and outcomes of hemospray as primary versus salvage therapeutic modality for endoscopic hemostasis: A retrospective cohort study”
AU  - Sheldon S. Smith
AU  - Andrew T. Mertz
AU  - Jerome C. Edelson
PY  - 2026
JO  - Journal of Investigative Medicine
DO  - 10.1177/10815589261483672
UR  - https://doi.org/10.1177/10815589261483672
ER  - 

APA

Smith, S. S., Mertz, A. T., & Edelson, J. C. (2026). Commentary on “The clinical utility and outcomes of hemospray as primary versus salvage therapeutic modality for endoscopic hemostasis: A retrospective cohort study”. Journal of Investigative Medicine. https://doi.org/10.1177/10815589261483672

Source records